BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37464398)

  • 1. Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family.
    Wang LH; Cao B; Li YL; Qiao BP
    BMC Cancer; 2023 Jul; 23(1):674. PubMed ID: 37464398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ANXA8 Regulates Proliferation of Human Non-Small Lung Cancer Cells A549 via EGFR-AKT-mTOR Signaling Pathway].
    Zhou GZ; Sun YH; Shi YY; Zhang Q; Zhang L; Cui LQ; Sun GC
    Mol Biol (Mosk); 2021; 55(5):870-880. PubMed ID: 34671007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A8 (ANXA8) regulates proliferation of porcine endometrial cells via Akt signalling pathway.
    Jiang X; Xue S; Kang T; Liu H; Ren H; Hua R; Ni D; Lei M
    Reprod Domest Anim; 2019 Jan; 54(1):3-10. PubMed ID: 30040162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of annexin A8 in the properties of pancreatic cancer.
    Hata H; Tatemichi M; Nakadate T
    Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of ANXA8 in Gastric Carcinoma.
    Ma F; Li X; Fang H; Jin Y; Sun Q; Li X
    J Cancer; 2020; 11(12):3551-3558. PubMed ID: 32284751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel binding partners (annexins) for the cell death signal phosphatidylserine and definition of their recognition motif.
    Rosenbaum S; Kreft S; Etich J; Frie C; Stermann J; Grskovic I; Frey B; Mielenz D; Pöschl E; Gaipl U; Paulsson M; Brachvogel B
    J Biol Chem; 2011 Feb; 286(7):5708-16. PubMed ID: 21131363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma.
    He ZH; Qin XH; Zhang XL; Yi JW; Han JY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):46-54. PubMed ID: 29364470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
    Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
    Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer.
    Wu W; Jia G; Chen L; Liu H; Xia S
    Front Genet; 2021; 12():731625. PubMed ID: 34484309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
    Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
    Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
    J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of retinal pigment epithelial cell phenotype by Annexin A8.
    Lueck K; Carr AF; Stampoulis D; Gerke V; Rescher U; Greenwood J; Moss SE
    Sci Rep; 2017 Jul; 7(1):4638. PubMed ID: 28680125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
    Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
    Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
    Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
    Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
    Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
    Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.